Viruses (Jul 2021)

Detection and Genetic Characterization of Hepatitis B and D Viruses: A Multi-Site Cross-Sectional Study of People Who Use Illicit Drugs in the Amazon Region

  • Ronylson José S. Silva,
  • Raquel Silva do Nascimento,
  • José Augusto J. Oliveira-Neto,
  • Fabricio Quaresma Silva,
  • Juliana Nádia F. Piauiense,
  • Camila Moraes Gomes,
  • Luiz Marcelo L. Pinheiro,
  • Rafael Lima Resque,
  • João Renato R. Pinho,
  • Emil Kupek,
  • Benedikt Fischer,
  • Luiz Fernando A. Machado,
  • Luísa Caricio Martins,
  • José Alexandre R. Lemos,
  • Aldemir B. Oliveira-Filho

DOI
https://doi.org/10.3390/v13071380
Journal volume & issue
Vol. 13, no. 7
p. 1380

Abstract

Read online

Hepatitis B (HBV) and delta (HDV) viruses are endemic in the Amazon region, but vaccine coverage against HBV is still limited. People who use illicit drugs (PWUDs) represent a high-risk group due to common risk behavior and socioeconomic factors that facilitate the acquisition and transmission of pathogens. The present study assessed the presence of HBV and HBV-HDV co-infection, identified viral sub-genotypes, and verified the occurrence of mutations in coding regions for HBsAg and part of the polymerase in HBV-infected PWUDs in municipalities of the Brazilian states of Amapá and Pará, in the Amazon region. In total, 1074 PWUDs provided blood samples and personal data in 30 municipalities of the Brazilian Amazon. HBV and HDV were detected by enzyme-linked immunosorbent assay and polymerase chain reaction. Viral genotypes were identified by nucleotide sequencing followed by phylogenetic analysis, whereas viral mutations were analyzed by specialized software. High rates of serological (32.2%) and molecular (7.2%) markers for HBV were detected, including cases of occult HBV infection (2.5%). Sub-genotypes A1, A2, D4, and F2a were most frequently found. Escape mutations due to vaccine and antiviral resistance were identified. Among PWUDs with HBV DNA, serological (19.5%) and molecular (11.7%) HDV markers were detected, such as HDV genotypes 1 and 3. These are worrying findings, presenting clear implications for urgent prevention and treatment needs for the carriers of these viruses.

Keywords